Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 13, 2018

SELL
$121.55 - $156.8 $323,809 - $417,715
-2,664 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$112.2 - $165.95 $298,900 - $442,090
2,664 New
2,664 $369,000
Q1 2018

May 15, 2018

SELL
$84.6 - $126.1 $232,311 - $346,270
-2,746 Closed
0 $0
Q4 2017

Feb 27, 2019

SELL
$91.55 - $115.85 $3,204 - $4,054
-35 Reduced 1.26%
2,746 $262,000
Q4 2017

Nov 21, 2018

BUY
$91.55 - $115.85 $3,204 - $4,054
35 Added 1.27%
2,781 $262,000
Q4 2017

Feb 14, 2018

BUY
$91.55 - $115.85 $251,396 - $318,124
2,746
2,746 $259,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $10.6B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Ibex Investors LLC Portfolio

Follow Ibex Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Investors LLC with notifications on news.